Home009420 • KRX
add
Hanall Biopharma Co Ltd
Previous close
₩41,950.00
Day range
₩41,650.00 - ₩43,500.00
Year range
₩24,000.00 - ₩57,100.00
Market cap
2.23T KRW
Avg Volume
1.13M
P/E ratio
938.26
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 40.80B | 10.76% |
Operating expense | 20.68B | 6.95% |
Net income | 298.96M | 34.71% |
Net profit margin | 0.73 | 21.67% |
Earnings per share | — | — |
EBITDA | 1.25B | 20.71% |
Effective tax rate | 12.77% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.93B | -56.16% |
Total assets | 201.82B | -5.21% |
Total liabilities | 44.17B | 6.26% |
Total equity | 157.65B | — |
Shares outstanding | 50.78M | — |
Price to book | 13.51 | — |
Return on assets | 0.44% | — |
Return on capital | 0.55% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 298.96M | 34.71% |
Cash from operations | 7.34B | 1.06% |
Cash from investing | -4.19B | 27.64% |
Cash from financing | 201.72M | 185.17% |
Net change in cash | 3.40B | 184.95% |
Free cash flow | 3.98B | 152.78% |
About
Founded
1973
Headquarters
Website
Employees
304
